← All organizations
Highest phase reached
Phase 1
First clinical trial
Aug 1, 2019Last known activity
Jul 24, 2025
Timeline
2010s
- Jan 1, 2017
Nanjing Bioheng Biotech Co., Ltd.— Founded
Drugs by trial phase (6 distinct, 19 trials)
Phase 1 (6 own, 0 via acquisition)
Indications
Recent trials (19)
- NCT07203404Lead sponsorEarly Phase 1Jul 24, 2025
- NCT07142161Lead sponsorEarly Phase 1Jul 20, 2025
- NCT06775912Lead sponsorEarly Phase 1Jan 15, 2025
- NCT06732492CollaboratorPhase 1Oct 31, 2024
- NCT06622694CollaboratorPhase 1Oct 7, 2024
- NCT06549296Lead sponsorEarly Phase 1Aug 31, 2024
- NCT06548620Lead sponsorEarly Phase 1Aug 31, 2024
- NCT06548607Lead sponsorEarly Phase 1Jul 29, 2024
- NCT05923541CollaboratorEarly Phase 1Jun 30, 2023
- NCT05902845CollaboratorEarly Phase 1Apr 30, 2023
- NCT05895994CollaboratorEarly Phase 1Mar 10, 2023
- NCT05907603CollaboratorEarly Phase 1Mar 8, 2023
- NCT05716113CollaboratorEarly Phase 1Feb 15, 2023
- NCT05015972CollaboratorEarly Phase 1Aug 20, 2021
- NCT04689204CollaboratorEarly Phase 1Dec 29, 2020
Details
- Founded
- Nanjing, CN Jan 1, 2017
- Last known activity
- Jul 24, 2025